Involvement of MGr1-Ag/37LRP in the vincristine-induced HIF-1 expression in gastric cancer cells

Molecular and Cellular Biochemistry

Volumn 303, Issue 1-2, 2007, Pages 151-160

  Liu, Lili ^a   Ning, Xiaoxuan ^a   Sun, Li ^a   Shi, Yongquan ^a   Han, Shuang ^a   Guo, Changcun ^a   Chen, Yu ^a   Sun, Shiren ^a   Yin, Fang ^a   Wu, Kaichun ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Hypoxia inducible factor 1; MGr1 Ag 37LRP; Vincristine

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; FOCAL ADHESION KINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LAMININ RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MULTIDRUG RESISTANCE PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; POLYPEPTIDE; PROTEIN PRECURSOR; SMALL INTERFERING RNA; VINCRISTINE;

ARTICLE; CANCER CELL; CANCER RESISTANCE; CANCER THERAPY; CONTROLLED STUDY; DNA BINDING; DRUG MECHANISM; GENE CONTROL; GENE INDUCTION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH CANCER; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLOTTING, WESTERN; CASPASE 3; CELL HYPOXIA; FOCAL ADHESION KINASE 1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 34547897004     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-007-9467-9     Document Type: Article

References (35)

1. Siddik ZH (2003) Cispatin: Mode of cytotoxic action and molecular basis of resistance. Oncogene 22:7265-7279
2. Correia JJ, Lobert S (2001) Physiochemical aspects of tubulin-interacting antimitotic drugs. Curr Pharm Des 7:1213-1228
3. Yun JJ, Jennifer SI, Sunmin L et al (2003) Microtubule disruption utilizes an NFγB-dependent pathway to stabilize HIF-1 protein. J Biol Chem 278:7445-7452
4. Osborn MT, Chambers TC (1996) Role of the stress-activiated/c-Jun NH2-terminal protein kinase pathway in the cellular response to Adriamycin and other chemotheraputic drugs. J Biol Chem 271:30950-30955
5. Shinoda C, Maruyama M, Fujishita T (2005) Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway. Int J cancer 117:21-31
6. Huang R, Myrry DJ, Kolwanker D (2006) Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell lines. Biochem Pharmacol 71:1695-1704
7. Cai XJ, Zhang XY, Fan DM (1994) Establishment of a multidrug- resistant gastric cancer cell line and its biological characteristics (in Chinese with English abstract). Chin J Clin Oncol 2S 67-71
8. Shi YQ, Zhai HH, Wang X et al (2002) Multidrug- resistance-associated protein MGr1-Ag is identical to the human 37-kDa laminin receptor precursor. Cell Mol Life Sci 59:1577-1583
9. Shi YQ, Han Y, Wang X et al (2002) MGr1-Ag is associated with multidrug-resistant phenotype of gastric cancer cells. Gastric Cancer 5154-5159
10. Sun L, Sh YQ, Guo CC et al (2006) Regulation of multidrug resistance by MGr1-Ag in gastric cancer cells. Tumor Bio 27:27-35
11. Jin WC, Suk JH, Kee JK et al (2003) 37-kDa laminin receptor precursor modulates cytotoxic necrotizing factor 1-mediated RhoA activation and bacterial uptake. J Biol Chem 278:16857-16862
12. Fan DM, Xiao B, Shi YQ et al (1998) A novel cDNA fragment associated with gastric cancer drug resistance was screened out from a library by monoclonal antibody MGr1. World J Gastroenterol 4S2:110-111
13. MF L, Fan DM, Zhou SJ (1995) Preparation and identification of monoclonal antibody associated with gastric cancer multidrug resistance (in Chinese with English abstract). Mod Oncol 3143-3145
14. Shiratsuchi H, Basson MD (2004) Extracellular pressure stimulates macrophage phagocytosis by inhibiting a pathway involving FAK and ERK. Am J Physiol Cell Physiol 286:1358-1366
15. Treins C, Giorgetti-Peraldi S, Murdaca J (2002) Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/ target of rapamycin- dependent signaling pathway. J Biol Chem 277:27975-27981
16. Semenza GL (2000) Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 35:71-103
17. Wenger RH (2002) Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia- inducible transcription factors, and O2-regulated gene expression. FASEB J 16:1151-1162
18. Danie PS, Wolfgang J, Roland HW et al (2002) Normoxic induction of the hypoxia- inducible factor 1α by insulin and interleukin-1β involves the phosphatidylinositol 3-kinase pathway. FEBS lett 512:157-162
19. Daniela T, Angela I, Gabriella Z et al (2005) Involvement of PI3K and MAPK Signaling in bcl-2-induced vascular endothelial growth factor expression in melanoma cells. Mol Biol Cell 16:4153-4162
20. Cruet HS, Troussard A, Fazli L et al (2004) Regulation of tumor angiogenesis by integrin-linked kinase (ILK). Cancer cell 5:79-90
21. John DH, David AC (2002) Role of integrins in cell invasion and migration. Nat Rev Cancer 291-300
22. Hazlehurst LA, Damiano JS, Buyuksal I et al (2000) Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR). Oncogene 7:4319-4327
23. Hecker IP, Gladson CI (2003) Focal adhesion Kinase in cancer. Front Bio-Sci 8705-5714
24. Gordon W. McLean NO, Carragher et al (2005) The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer 5505-5515
25. Haber M, Norris MD, Kavallaris M et al (1989) Multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein. Cancer Res 49:5281-5289
26. Beck WT (1983) Vinca alkaloid-resistant phenotype in cultured human leukaemic lymphoblasts. Cancer Treat Rep 67:875-882
27. Chung J, Yoon S, Datta K et al (2004) Hypoxia-induced vascular endothelial growth factor transcription and protection from apoptosis are dependent on α6β1 integrin in breast carcinoma cells. Cancer Res 64:4711-4716
28. Kavallaris M, Tait S, Walsh BJ et al (2001) Multiple microtubule alterations are associated with vinca alkaloid resistance in human leukemia cells. Cancer Res 61:5803-5809
29. Christine LF, Leslie RW, Steven RE (1999) Yeast proteins related to the p40/laminin receptor precursor are required for 20S ribosomal RNA processing and the maturation of 40S ribosomal subunits. Cancer Res 59:704-710
30. Ewen ME, Oliver CJ, Sluss HK et al (1995) p53-dependent repression of CDK4 translation in TGF-β-induced G1 cell-cycle arrest. Genes Dev 9:204-217
31. Hengst L, Reed IS (1996) Translational control of p27Kip1 accumulation during the cell cycle. Science 271:1861-1864 (Washington DC)
32. Polymenis M, Schmidt EV (1997) Coupling of cell division to cell growth by translational control of the G1 cyclin CLN3 in yeast. Genes Dev 11:2522-2531
33. Diaz-Montero CM, Wygant JN (2006) McIntyre BW.PI3-K/Akt-mediated anoikis resistance of human osteosarcoma cells requires Src activation. Eur J Cancer 42(10):1491-1500
34. Giancotti FG, Tarone G (2003) Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu Rev Cell Dev Biol 19:173-206
35. Garg A, Aggarwal BB (2002) Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia 16:1053-1068